Acquisition brings together PerkinElmer’s Project Farma’s CQV, project delivery, and quality expertise with SimoTech’s DCS, MES, SCADA, and GMP IT experience to strengthen global manufacturing services platform.
Cork, Ireland, August 11, 2026 – Project Farma, PerkinElmer’s leading provider of Good Manufacturing Practice (GMP) manufacturing services, today announced it has entered into a definitive agreement to acquire SimoTech, a trusted provider of manufacturing automation and GMP IT solutions to the life sciences industry. Terms of the acquisition were not disclosed.
Founded in 2011 and headquartered in Cork, Ireland, SimoTech has grown to become the largest Irish-owned automation and manufacturing IT company, serving 10 of the top 20 global pharma and biotech manufacturers. SimoTech partners with multinational life science organizations to design, build, and operate critical process automation systems that fast-track project delivery and provide operational efficiency and manufacturing agility, while achieving regulatory compliance.
This acquisition marks the latest step in Project Farma’s expansion of its manufacturing and engineering solutions platform, further solidifying its standing as a premier provider of life sciences engineering and technical services, helping customers accelerate the manufacturing of life-saving treatments and bringing therapies to patients faster worldwide. Project Farma’s expertise spans facility commissioning, qualification and validation (CQV), project management, scheduling and controls, and quality, regulatory and compliance. These capabilities have made it a trusted partner for the industry’s most complex challenges. SimoTech brings the automation, digital manufacturing, and GMP IT capabilities customers have sought most consistently. Together, the platforms offer a complete end-to-end solution from strategic planning and project execution to operational readiness and ongoing operations.
Pat Desmond, SimoTech Chief Executive Officer, commented, “Joining Project Farma is a transformational chapter for SimoTech. For more than a decade, we’ve built our reputation by partnering with the world’s leading biopharma manufacturers to design, build, operate, and optimize their most critical automation and digital systems. That mission hasn’t changed, and neither have the teams our customers rely on. Joining Project Farma gives us the global reach, commercial infrastructure, and resources to deliver for our customers at a scale that maximizes our impact worldwide.”
“SimoTech’s capabilities are a natural complement to Project Farma’s platform. Together, we are well positioned to offer customers a more complete, integrated manufacturing services solution” said Rich Tree, Project Farma President. “For a company founded on the belief that better manufacturing means faster access to life-saving treatments, this acquisition is a direct expression of our mission”, he concluded.
SimoTech’s customer teams, relationships, and ways of working will continue unchanged as SimoTech joins Project Farma, with existing customers receiving the same expert support from the team that has earned their trust.
The transaction is expected to close following the satisfaction of customary closing conditions, including receipt of applicable regulatory approvals.
